Atrial Fibrillation

Latest News

FDA Clears Personal ECG Device for Bradycardia, Tachycardia Detection

The FDA has cleared KardiaMobile (AliveCor), a personal ECG device, for use in detecting bradycardia and tachycardia.

AI Able to Identify Cardiac Rhythm Devices From Radiographs

A neural network can accurately identify the manufacturer and model group of a cardiac rhythm device from a chest radiograph.

Factors Associated With Bleeding Events in Anticoagulated Patients With Afib

Attending to modifiable risk factors is an important treatment target in patients with atrial fibrillation treated with anticoagulants to reduce thromboembolic and bleeding events.

Female Sex Independently Associated With Worse Catheter Ablation Outcomes in Afib

Women have higher rates of complications and hospital readmission following atrial fibrillation ablation independent of age, comorbidities, and hospital factors.

Anemia in Atrial Fibrillation Linked to Increased Bleeding Risk

Anemia in patients with atrial fibrillation is associated with major bleeding and lower time in therapeutic range.

Significant Improvements in QoL With Catheter Ablation in Atrial Fibrillation

Compared with medical therapy, catheter ablation led to clinically important and significant improvements in quality of life at 12 months in patients with symptomatic atrial fibrillation.

FDA Grants Breakthrough Therapy Designation to Ticagrelor Reversal Agent

The FDA has granted Breakthrough Therapy designation to PB2452, an investigational reversal agent for ticagrelor.

FDA Warns Against Use of Preowned or Unauthorized INR Test Strips

The FDA is warning patients not to use preowned test strips or test strips not authorized for sale in the US for possible infection.

Ready-to-Administer Adenosine Simplist Syringes Now Available

Fresenius Kabi announced the launch of Adenosine Injection in single-dose Simplist ready-to-administer prefilled syringes.

Computer Model Predicts Ventricular Arrhythmia Risk in Arrhythmogenic RV Cardiomyopathy

A new model can predict the risk for incident ventricular arrhythmias (VAs) in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.